Cargando…

Bromocriptine and insulin sensitivity in lean and obese subjects

Bromocriptine is a glucose-lowering drug, which was shown to be effective in obese subjects with insulin resistance. It is usually administered in the morning. The exact working mechanism of bromocriptine still has to be elucidated. Therefore, in this open-label randomized prospective cross-over mec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahler, L, Verberne, H J, Brakema, E, Tepaske, R, Booij, J, Hoekstra, J B, Holleman, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097144/ https://www.ncbi.nlm.nih.gov/pubmed/27758845 http://dx.doi.org/10.1530/EC-16-0051

Ejemplares similares

(18)F-FDG uptake in the colon is modulated by metformin but not associated with core body temperature and energy expenditure
por: Bahler, Lonneke, et al.
Publicado: (2017)

Multiorgan Insulin Sensitivity in Lean and Obese Subjects
por: Conte, Caterina, et al.
Publicado: (2012)

Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects
por: Bouter, KEC, et al.
Publicado: (2018)

Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
por: Gaziano, J. Michael, et al.
Publicado: (2012)

Insulin Modulation of Magnetoencephalographic Resting State Dynamics in Lean and Obese Subjects
por: Stingl, Krunoslav T., et al.
Publicado: (2010)

Effects of Bromocriptine on Glucose and Insulin Dynamics in Normal and Insulin Dysregulated Horses
por: Loos, Caroline M. M., et al.
Publicado: (2022)

Fasting and postprandial levels of ghrelin, leptin and insulin in lean, obese and anorexic subjects
por: Korek, Emilia, et al.
Publicado: (2013)

Prediction of response to bromocriptine in acromegaly.
por: Atkinson, A. B., et al.
Publicado: (1978)

Serum sclerostin is negatively associated with insulin sensitivity in obese but not lean women
por: Aznou, Anouar, et al.
Publicado: (2021)

Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
Publicado: (2015)

Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

Repurposing of Bromocriptine for Cancer Therapy
por: Seo, Ean-Jeong, et al.
Publicado: (2018)

Central Hyperthermia Treated with Bromocriptine
por: Natteru, P., et al.
Publicado: (2017)

Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells
por: Huang, Jinxiang, et al.
Publicado: (2017)

Bromocriptine, a clinical and pharmacological review /
por: Thorner, Michael O.
Publicado: (1980)

Bromocriptine in type 2 diabetes mellitus
por: Shivaprasad, C., et al.
Publicado: (2011)

Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
por: Simon, Rebecca, et al.
Publicado: (2018)

Management of pituitary tumour apoplexy with bromocriptine in pregnancy
por: Janssen, Nina M, et al.
Publicado: (2012)

Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls
por: Henquin, Jean-Claude, et al.
Publicado: (2017)

Bromocriptine as a new therapeutic agent for peripartum cardiomyopathy
por: Chopra, Sandeep, et al.
Publicado: (2012)

Bromocriptine Does Not Alter Speed–Accuracy Tradeoff
por: Winkel, Jasper, et al.
Publicado: (2012)

Relationships of serum soluble E-selectin concentration with insulin sensitivity and metabolic flexibility in lean and obese women
por: Adamska, Agnieszka, et al.
Publicado: (2013)

Sweet/Fat Preference Taste in Subjects Who are Lean, Obese and Very Obese
por: Leohr, Jennifer, et al.
Publicado: (2020)

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus
por: Chamarthi, Bindu, et al.
Publicado: (2015)

Repositioning of bromocriptine for treatment of acute myeloid leukemia
por: Lara-Castillo, María Carmen, et al.
Publicado: (2016)

Effects of tolcapone and bromocriptine on cognitive stability and flexibility
por: Cameron, Ian G. M., et al.
Publicado: (2018)

Insulin Sensitizers May Attenuate Lean Mass Loss in Older Men With Diabetes
por: Lee, Christine G., et al.
Publicado: (2011)

Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study
por: Qian, Xin, et al.
Publicado: (2018)

Insulin secretion and sensitivity during oral glucose tolerance test in Korean lean elderly women.
por: Kim, J., et al.
Publicado: (2001)

Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis
por: Jiang, Yan-Nian, et al.
Publicado: (2007)

Evaluation of Transcriptomic Regulations behind Metabolic Syndrome in Obese and Lean Subjects
por: Paczkowska-Abdulsalam, Magdalena, et al.
Publicado: (2020)

Food-induced cortisol secretion is comparable in lean and obese male subjects
por: Arroyo Tardio, Patricia, et al.
Publicado: (2023)

Association of the gut microbiota with clinical variables in obese and lean Emirati subjects
por: Ahmad, Manal Ali, et al.
Publicado: (2023)

Hormone-Sensitive Lipase Serine Phosphorylation and Glycerol Exchange Across Skeletal Muscle in Lean and Obese Subjects : Effect of β-Adrenergic Stimulation
por: Jocken, Johan W.E., et al.
Publicado: (2008)

Insulin resistance, leptin and adiponectin in lean and hypothyroid children and adolescents with obesity
por: El Amrousy, Doaa, et al.
Publicado: (2022)

Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects
por: Bakker, Guido J., et al.
Publicado: (2019)

Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study
por: Roe, Erin D., et al.
Publicado: (2015)

Diabetes Patients' Experiences With the Implementation of Insulin Therapy and Their Perceptions of Computer-Assisted Self-Management Systems for Insulin Therapy
por: Simon, Airin CR, et al.
Publicado: (2014)

Gonadotropin Response to Insulin and Lipid Infusion Reproduces the Reprometabolic Syndrome of Obesity in Lean Women
por: Santoro, Nanette F, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ah6k5dleijuh4db16u6jgr4sdr